Loading…
Krokus Pharma / Crocus Pharma (კროკუს ფარმა) — a Georgian pharmaceutical manufacturer of its own branded products (e.g. Crocsiderm dermatological cream), distributed through third-party pharmacy chains such as Pharmadepot and Aversi. Fast-growing with brand-owner margins (gross margin ~60%).
| Line item | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|
| Total Revenue | 1,722 | 2,595 | 4,156 | +55.3% |
| Total COGS | 708 | 819 | 1,741 | +56.8% |
| Gross Profit | 1,014 | 1,775 | 2,415 | +54.3% |
| Gross Margin | 58.9% | 68.4% | 58.1% | |
| 533 | 769 | 998 | +36.8% | |
| EBITDA | 481 | 1,006 | 1,417 | +71.7% |
| EBITDA Margin | 27.9% | 38.8% | 34.1% | |
| Total D&A | 3 | 3 | 8 | +57.2% |
| EBIT / Operating Income | 478 | 1,003 | 1,409 | +71.8% |
| Total Interest Expense | 2 | 2 | 0 | +9.4% |
| 55 | 6 | 62 | nmf | |
| Profit Before Tax | 530 | 995 | 1,347 | +59.4% |
| Total Income Tax | 8 | 0 | 74 | +197.3% |
| Net Profit / (Loss) | 522 | 995 | 1,273 | +56.2% |
| Net Margin | 30.3% | 38.4% | 30.6% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →